Previous close | 9.38 |
Open | 9.40 |
Bid | 9.34 x 1100 |
Ask | 9.64 x 1000 |
Day's range | 9.24 - 9.43 |
52-week range | 7.52 - 11.56 |
Volume | |
Avg. volume | 413,330 |
Market cap | 864.886M |
Beta (5Y monthly) | 0.97 |
PE ratio (TTM) | 470.50 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK & LONDON & HONG KONG, May 29, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Executive Officer, Oleg Movchan, and Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will participate at the following investor events:
NEW YORK & LONDON & HONG KONG, May 09, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its first quarter 2024 financial results as part of its 1Q 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com.
NEW YORK & LONDON & HONG KONG, April 18, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its first quarter 2024 financial results before the U.S. financial markets open on Thursday, May 9, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results.